Shopping Cart
- Remove All
- Your shopping cart is currently empty
Strontium ranelate (S12911), a strontium (II) salt of the ranelic acid, is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA) indicated for use in the treatment of severe osteoporosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $32 | In Stock | |
25 mg | $48 | In Stock | |
50 mg | $79 | In Stock | |
100 mg | $117 | In Stock | |
200 mg | $197 | In Stock | |
500 mg | $450 | In Stock |
Description | Strontium ranelate (S12911), a strontium (II) salt of the ranelic acid, is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA) indicated for use in the treatment of severe osteoporosis. |
Targets&IC50 | Ca2+ channel:0.5 mM |
Alias | S12911, Distrontium renelate |
Molecular Weight | 513.49 |
Formula | C12H6N2O8S·2Sr |
Cas No. | 135459-87-9 |
Smiles | [Sr+2].c1(c(c(c(s1)N(CC(=O)[O-])CC(=O)[O-])C#N)CC(=O)[O-])C(=O)[O-].[Sr+2] |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 5.13 mg/ml (10 mM), Sonication is recommended. H2O: Insoluble | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.